Screener/Healthcare/Biotechnology

FULC

Fulcrum Therapeutics, Inc.NASDAQ
$6.71-0.18 (-2.61%)
Small CapUnder $10Healthcare
$2.31
$15.74
$6.56
$6.82
EPS (TTM)$-1.18
P/E Ratio—
Dividend Yield—
Market Cap$428.0M
Volume841K
Prev Close$6.89
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q2 '25$0-$17.3M$-0.28——
Q1 '25$0-$17.7M$-0.28——
Q4 '24$0-$16.6M$-0.27——
Q3 '24$0-$21.7M$-0.35——
Q2 '24$80.0M$55.4M$0.87—69.3%
Q1 '24$0-$26.9M$-0.43——
Q4 '23$871K-$24.8M$-0.40—-2842.3%
Q3 '23$759K-$24.0M$-0.39—-3164.3%
Get Your Daily Market Recap